BIO Stock Overview
Biofarm S.A. manufactures and sells medicines in Romania.
Biofarm S.A. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||RON0.80|
|52 Week High||RON0.84|
|52 Week Low||RON0.58|
|1 Month Change||3.90%|
|3 Month Change||8.40%|
|1 Year Change||34.23%|
|3 Year Change||95.12%|
|5 Year Change||137.39%|
|Change since IPO||106.84%|
Recent News & Updates
Is Biofarm S.A.'s (BVB:BIO) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?Mar 18
Is There More To The Story Than Biofarm's (BVB:BIO) Earnings Growth?Feb 18
Shareholders Of Biofarm (BVB:BIO) Must Be Happy With Their 140% Total ReturnJan 23
A Look At The Intrinsic Value Of Biofarm S.A. (BVB:BIO)Dec 25
Could The Biofarm S.A. (BVB:BIO) Ownership Structure Tell Us Something Useful?Dec 03
|BIO||RO Pharmaceuticals||RO Market|
Return vs Industry: BIO exceeded the RO Pharmaceuticals industry which returned 2.9% over the past year.
Return vs Market: BIO exceeded the RO Market which returned 10.7% over the past year.
|BIO Average Weekly Movement||2.3%|
|Pharmaceuticals Industry Average Movement||5.2%|
|Market Average Movement||3.0%|
|10% most volatile stocks in RO Market||7.1%|
|10% least volatile stocks in RO Market||2.3%|
Stable Share Price: BIO is less volatile than 75% of RO stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: BIO's weekly volatility (2%) has been stable over the past year.
About the Company
Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatological, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmologic, musculoskeletal, respiratory and ENT, and neurological. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products.
Biofarm S.A. Fundamentals Summary
|BIO fundamental statistics|
Is BIO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BIO income statement (TTM)|
|Cost of Revenue||RON53.94m|
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
|Earnings per share (EPS)||0.076|
|Net Profit Margin||25.29%|
How did BIO perform over the long term?See historical performance and comparison